Medibank Private Limited (MPL.AX)
- Previous Close
3.6400 - Open
3.6500 - Bid 3.6100 x 19063300
- Ask 3.6300 x 2164900
- Day's Range
3.6100 - 3.6700 - 52 Week Range
3.3300 - 3.9400 - Volume
3,365,038 - Avg. Volume
5,990,796 - Market Cap (intraday)
9.969B - Beta (5Y Monthly) 0.11
- PE Ratio (TTM)
15.74 - EPS (TTM)
0.2300 - Earnings Date Feb 22, 2024
- Forward Dividend & Yield 0.14 (3.96%)
- Ex-Dividend Date Feb 29, 2024
- 1y Target Est
3.90
Medibank Private Limited provides private health insurance and health services in Australia. The company operates in two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers members with health cover for hospital treatments; and ancillary cover, which provides members with health cover for healthcare services, such as dental, optical, and physiotherapy. This segment also offers health insurance products to overseas visitors and overseas students. The Medibank Health segment provides health management and in-home care services, as well as a range of telehealth services to government and corporate customers; and distributes travel, life, and pet insurance products. The company underwrites its health insurance products under the Medibank and ahm brands. Medibank Private Limited was founded in 1976 and is based in Docklands, Australia.
www.medibank.com.au3,242
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Recent News: MPL.AX
Performance Overview: MPL.AX
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MPL.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MPL.AX
Valuation Measures
Market Cap
10.02B
Enterprise Value
9.54B
Trailing P/E
16.11
Forward P/E
16.81
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.27
Price/Book (mrq)
4.26
Enterprise Value/Revenue
1.21
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
8.63%
Return on Assets (ttm)
15.24%
Return on Equity (ttm)
31.67%
Revenue (ttm)
7.94B
Net Income Avi to Common (ttm)
685.4M
Diluted EPS (ttm)
0.2300
Balance Sheet and Cash Flow
Total Cash (mrq)
3.15B
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
80.49M
Research Analysis: MPL.AX
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: MPL.AX
MPL.AX does not have Company Insights